Bioworld Financial Watch articles from March 2008

Bioworld Financial Watch archives from March 2008

PFS coming into its own, but just one factor in Avastin ok.(progression-free survival)
March 3, 2008... Now that the initial surprise has worn off regarding the FDA's decision to grant accelerated approval for Genentech Inc.'s Avastin (bevacizumab) in breast cancer, the industry can begin to digest the implications of that decision. Top of...

Money raised by biotech in 2008 vs. 2007.(Statistical table)(Brief article)
March 3, 2008... Money Raised By Biotech In 2008 Vs. 2007 Jan. 1 - Feb. 28, 2008: Jan. 1 - March 1, 2007: $2,565.05M $4,075.47M Public/Other * 930 1,564...

10 biggest U.S. gainers for the week.(Statistical table)(Brief article)
March 3, 2008... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Barrier Therapeutics 37.74 Gilead Sciences 4.40 Momenta Pharma 37.11 Genentech 4.15 Nanogen 33.33 LifeCell...

10 biggest U.S. losers for the week.(Statistical table)(Brief article)
March 3, 2008... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) EpiCept -35.10 Cepheid -2.46 NeurogesX -28.82 XenoPort -2.44 VioQuest Pharma -20.00...

Collaborations between biotechnology companies and government/nonprofit institutions: Oct. 19 -Feb. 28, 2007.(Report)(Table)
March 3, 2008... Collaborations Between Biotechnology Companies And Government/Nonprofit Institutions: Oct. 19 - Feb. 28, 2007 Company * (Country; University/Nonprofit @ Type Of Agreement Symbol) Accelr8 Technology Washington University in...

BioWorld stock report for public biotechnology companies.(Market share report)(Statistical data)
March 3, 2008... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change Vol 2/22 2/29 WK YTD (000) Aastrom Biosci ASTM 0.62 0.52...

Canceled panel, delays could signal trouble for telavancin.(Ceftobiprole Next Antibiotic in Line)
March 10, 2008... It's been a bumpy ride lately for Theravance Inc., and, in many ways, for the antibiotic space in general. Following an approvable letter in October for its antibiotic candidate, telavancin, in complicated skin and skin structure infections...

Money raised by biotech in 2008 vs. 2007.(Brief article)
March 10, 2008... Money Raised By Biotech In 2008 Vs. 2007 Jan. 1 - March 6, 2008: Jan. 1 - March 8, 2007: $2,703.44M $4,624.54M Public Offerings 1,058 1,280 Public/Other...

10 biggest U.S. gainers for the week.(Brief article)
March 10, 2008... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) EXACT Sciences 67.86 Genentech 3.64 Inovio Biomedical 54.26 Genzyme 2.54 Immtech Intl. 20.00 Integra...

10 biggest U.S. losers for the week.(Brief article)
March 10, 2008... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) Omrix Biopharma -35.40 Omrix Biopharma -8.55 ISTA Pharma -35.32 United Therapeutics -5.83 deCODE genetics -32.65 Theravance...

Public financing of biotechnology: February 2008.(Statistical table)
March 10, 2008... Public Financing Of Biotechnology: February 2008 I. COMMENCED TRADING IN FEBRUARY Company Date Date Shares/Units Price Shares (Symbol) # Filed Comm. (M) Out (M) @ INITIAL...

Other financings of public biotechnology companies: February 2008.(Statistical table)
March 10, 2008... Other Financings Of Public Biotechnology Companies: February 2008 TOTAL: $578.325M Company (Symbol) # Type Of Financing Number Of Amount Shares, Raised ...

Venture capital and other investments in private biotechnology companies: February 2008.
March 10, 2008... Venture Capital And Other Investments In Private Biotechnology Companies: February 2008 FINANCING OF PRIVATE BIOTECHNOLOGY COMPANIES:$244.94M Company Location Date Amt. (M) Details Adnavance Vancouver, 2/26...

Milestone payments from corporate partners: February 2008.(Table)
March 10, 2008... Milestone Payments From Corporate Partners: February 2008 TOTAL: $2.75M Year to Date: $73.17M Company (Symbol) # * Partner Amt. Details (Date) (Country) (M) Ablynx NV (Belgium; ...

Money raised by biotech in 2008: January-February.(Brief article)
March 10, 2008... Money Raised By Biotech In 2008: January -February Type of financing January February Total ($M) Public offerings 413.6 639.4 1,053.0 Public/other 352.0 578.3 930.3 Private biotechs 336.8 ...

BioWorld stock indicator 2008.(Brief article)
March 10, 2008... These graphs compare the performance of the biotech stocks for all of 2008 using two different measures. The BioWorld Stock Indicator measures the average percent change year to date in the 243 U.S. biotech and biotech-related stocks that...

BioWorld stock report for public biotechnology companies.(Statistical table)
March 10, 2008... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change Vol 2/29 3/7 WK YTD (000) Aastrom Biosci ASTM 0.52 0.45 ...

Biotech firms turn to reverse mergers in slow IPO market.
March 17, 2008... With the initial public offering market slowing, many private biotech companies are going the reverse merger route, seeking to combine their operations with either public companies that have fallen on hard times or public shells to gain access...

10 biggest U.S. gainers for the week.(Statistical table)(Brief article)
March 17, 2008... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Alliance Pharma 100.00 MacroChem 36.67 Lexicon 35.15 Trubion Pharma 33.01 Third Wave Techno 25.98 Santarus 24.74 Draxis Health ...

Money raised by biotech in 2008 Vs.2007.(Brief article)
March 17, 2008... Money Raised By Biotech In 2008 Vs. 2007 Jan. 1 - March 13, 2008: Jan. 1 - March 15, 2007: $2,874.11M $4,863.24M Public Offerings 1,134 1,318...

10 biggest U.S. losers for the week.(Statistical table)(Brief article)
March 17, 2008... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) Keryx Biopharma -87.83 Progenics Pharma -64.41 Genitope -56.25 ISTA Pharma -51.29 Cellegy Pharma -50.00 Helicos -37.95...

Phase I clinical trials update: February 2008.(Chart)
March 17, 2008... Phase I Clinical Trials Update: February 2008 Company * (Country; Product Description Symbol) AUTOIMMUNE Alvine Pharmaceuticals ALV003 An orally administered drug Inc. * ...

Phase II clinical trials update: February 2008.(Chart)
March 17, 2008... Phase II Clinical Trials Update: February 2008 Company * (Country; Product Description Symbol) AUTOIMMUNE Celgene Corp. (CELG) CC-10004 Apremilast CANCER AEterna Zentaris Inc. ...

Pivotal/phase III clinical trials update: February 2008.(Chart)
March 17, 2008... Pivotal/Phase III Clinical Trials Update: February 2008 Company * (Country; Product Description Symbol) AUTOIMMUNE Centocor Inc. (unit of Ustekinumab A human monoclonal Johnson & Johnson) ...

Non-U.S. clinical trials and regulatory actions: February 2008.(Chart)
March 17, 2008... Non-U.S. Clinical Trials And Regulatory Actions: February 2008 Company * (Country; Product Description Symbol) CANCER ActivBiotics * M40403 A small molecule that ...

FDA submissions, approvals and other actions: February 2008.
March 17, 2008... FDA Submissions, Approvals And Other Actions: February 2008 Company * (Country; Product Description Symbol) AUTOIMMUNE Abbott (NYSE:ABT) Humira Adalimumab (FDA-approved) UCB...

BioWorld stock report for public biotechnology companies.(Statistical table)
March 17, 2008... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change Vol 3/7 3/14 WK YTD (000) Aastrom Biosci ASTM 0.45 0.42 ...

New clinical trial mandate poses concerns for drug firms.
March 24, 2008... Reports that clinical trial data were being suppressed led Congress last fall to pass legislation requiring drug-makers to submit study information, other than Phase I, to a publicly accessible registry and results database. The law,...

Money raised by biotech in 2008 vs. 2007.(Brief article)
March 24, 2008... Money Raised By Biotech In 2008 Vs. 2007 Jan. 1--March 20, 2008: Jan. 1--March 22, 2007: $3,039.31M $5,309.53M Public Offerings 1,143 1,324...

10 biggest U.S. gainers for the week.(Brief article)
March 24, 2008... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) (By Dollars) Neurogen 93.71 Illumina 4.63 ISTA Pharma 69.70 United Therapeutics 4.55 QLT Inc. 40.41 Cephalon...

10 biggest U.S. losers for the week.(Brief article)
March 24, 2008... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) (By Dollars) VioQuest Pharma -45.45 Amgen -4.35 Vion Phanna -39.84 Auxilium Phanna -3.71 EpiCept -33.75 XenoPort ...

Grants, contracts and awards to Biotech Companies: July 27, 2007 - March 20, 2008.(Statistical table)
March 24, 2008... Company * Funding Amount (Country; Symbol) Institution (US$M) A&G Avon Foundation $0.87 Pharmaceutical * Breast Cancer ...

BioWorld stock report for Public Biotechnology Companies.(Market share report)
March 24, 2008... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change Vol 3/14 3/21 WK YTD (000) Aastrom Biosci ASTM 0.42 0.39 -7.14...

New guidelines, safety issues reshape diabetes space.
March 31, 2008... The diabetes landscape is a tad riskier for drugs in development that have a safety glitch or two, and the bottom line could mean higher costs. New FDA draft guidance calls for more patients and lengthier trials for companies with certain...

Money raised by biotech in 2008 vs. 2007.(Statistical table)(Brief article)
March 31, 2008... Money Raised By Biotech In 2008 Vs. 2007 Jan. 1 - March 27, 2008: Jan. 1 - March 29, 2007: $3,239.31M $5,730.66M Public Offerings 1,143 1,365...

10 biggest U.S. gainers for the week.(Statistical table)(Brief article)
March 31, 2008... 10 BIGGEST U.S. GAINERS FOR THE WEEK (By Percent) Immtech Intl. 53.33 Titan Pharma 51.52 VioQuest Pharma 33.33 Vanda Pharma 31.75 Generex Biotech 25.84 Cellegy Pharma 25.00 Cerus ...

10 biggest U.S. losers for the week.(Statistical table)(Brief article)
March 31, 2008... 10 BIGGEST U.S. LOSERS FOR THE WEEK (By Percent) SGX Pharma -65.60 Accentia Biopharm -57.49 Neurogen -33.77 BioMimetic Thera -33.31 Replidyne -22.62 Emisphere Tech -15.38 ISTA...

Biotech mergers and acquisitions: Nov. 30, 2007 - March 27, 2008.(Aspreva Pharmaceuticals corp. )
March 31, 2008... Biotech Mergers And Acquisitions: Nov. 30, 2007 - March 27, 2008 # I. COMPLETED MERGERS AND ACQUISITIONS Company Acquired By Date Date Acquired * Or Merged With Announced Completed...

BioWorld stock report for public biotechnology companies.(Market share report)
March 31, 2008... BioWorld Stock Report For Public Biotechnology Companies Company Symbol Close Close %Change Vol 3/21 3/28 WK YTD (000) Aastrom Biosci ASTM 0.39 0.43 10.26...